Article: Founder of MelTec GmbH and Proteomics Researcher, Walter Schubert of Otto-von-Guericke University Awarded U.S. Patents for Amyotrophic Lateral Sclerosis.

Business Editors/Health/Medical Writers

MAGDEBURG, Germany--(BUSINESS WIRE)--July 16, 2003

Walter Schubert, university educator, founder and partner of MelTec GmbH today announced that he has been awarded three U.S. patents related to Amyotrophic Lateral Sclerosis (ALS). ALS is a devastating neurological disease the cause of which is unknown. It affects the motor neurons of the brain and spinal cord, while leaving the intellect usually completely intact throughout the course of the disease. Apart from a few unconvincing claims of recovery, ALS is a fatal disease, with a mean duration of two to four years. Severe breathing problems occur due to impairment ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!